CME Group announced that its S&P UBS USD Liquid Leveraged Loan Index futures began trading on September 14, 2026. The new contracts track the S&P UBS index and offer a centrally cleared, capital-efficient tool for relative value trading, according to the Chicago-based derivatives marketplace. Ted Carey, Executive Director of Rates and OTC Products at CME Group, said the futures give institutions risk management tools beyond investment grade and high-yield markets, with cross-margining benefits within a single clearing house. Cameron Drinkwater, Chief Product and Operations Officer at S&P Dow Jones Indices, called it the first-of-its-kind exchange-traded futures contract linked to a transparent and representative leveraged loan benchmark. CME Group credit futures launched in June 2024, and since then over 1.5 million contracts have traded across the complex, with open interest exceeding $2 billion in September 2026. The contracts can provide automatic margin offsets against CME Group's interest rate and equity futures, part of the $95 billion in daily efficiencies the company delivers to clients across asset classes, and are available to trade on CME Globex and eligible for submission to clearing via CME ClearPort.
CME Group IncCME launched first-of-its-kind S&P UBS USD Liquid Leveraged Loan Index futures, expanding its product suite and cross-margining offerings.
Taishin Financial Holding Co Ltd